Interference with Redox-Active Enzymes as a Basis for the Design of Antimalarial Drugs

E-ISSN： 1875-5607|6|2|163-176

ISSN： 1389-5575

Source： Mini Reviews in Medicinal Chemistry, Vol.6, Iss.2, 2006-02, pp. : 163-176

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Physico-Biochemical Study on Potential Redox-Cyclers as Antimalarial and Antischistosomal Drugs

Current Pharmaceutical Design, Vol. 18, Iss. 24, 2012-08 ,pp. : 3539-3566

Bentham Science Publishers

Access to resources Recommend Favorite

Redox-active and Redox-silent Compounds: Synergistic Therapeutics in Cancer

Current Medicinal Chemistry, Vol. 22, Iss. 5, 2015-02 ,pp. : 552-568

Bentham Science Publishers

Access to resources Recommend Favorite

Rational Design of Antimalarial Drugs Using Molecular Modeling and Statistical Analysis

Current Pharmaceutical Design, Vol. 21, Iss. 28, 2015-08 ,pp. : 4112-4127

Bentham Science Publishers

Access to resources Recommend Favorite

Emerging targets for antimalarial drugs

By Rangarajan Pundi N Padmanaban Govinarajan

Expert Opinion on Therapeutic Targets, Vol. 5, Iss. 4, 2001-08 ,pp. : 423-441

Informa Healthcare

Access to resources Recommend Favorite

Antimalarial Drugs and their Useful Therapeutic Lives: Rational Drug Design Lessons from Pleiotropic Action of Quinolines and Artemisinins

Current Drug Discovery Technologies, Vol. 7, Iss. 4, 2010-12 ,pp. : 280-316

Bentham Science Publishers

Access to resources Recommend Favorite